首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   9727篇
  免费   1020篇
  国内免费   59篇
耳鼻咽喉   54篇
儿科学   265篇
妇产科学   109篇
基础医学   1156篇
口腔科学   544篇
临床医学   1029篇
内科学   1802篇
皮肤病学   124篇
神经病学   645篇
特种医学   582篇
外科学   1011篇
综合类   396篇
一般理论   1篇
预防医学   1320篇
眼科学   269篇
药学   871篇
中国医学   36篇
肿瘤学   592篇
  2021年   124篇
  2020年   75篇
  2019年   127篇
  2018年   135篇
  2017年   111篇
  2016年   132篇
  2015年   165篇
  2014年   201篇
  2013年   307篇
  2012年   365篇
  2011年   446篇
  2010年   290篇
  2009年   216篇
  2008年   321篇
  2007年   372篇
  2006年   377篇
  2005年   408篇
  2004年   457篇
  2003年   413篇
  2002年   473篇
  2001年   434篇
  2000年   366篇
  1999年   324篇
  1998年   215篇
  1997年   215篇
  1996年   166篇
  1995年   131篇
  1994年   128篇
  1993年   146篇
  1992年   190篇
  1991年   197篇
  1990年   234篇
  1989年   223篇
  1988年   190篇
  1987年   192篇
  1986年   184篇
  1985年   169篇
  1984年   135篇
  1983年   126篇
  1982年   96篇
  1981年   80篇
  1980年   56篇
  1979年   90篇
  1978年   73篇
  1977年   79篇
  1976年   81篇
  1975年   67篇
  1974年   61篇
  1973年   66篇
  1970年   57篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.
62.
BACKGROUND: While Tacrolimus (Tac) and Cyclosporine (Cya) immunosuppression are used after cardiac transplantation (tx), few studies have evaluated their use in pediatric patients. METHODS: We randomized 26 heart transplant recipients (pts) in a prospective, open-label trial to Tac (n = 14) or Cya (n = 12) to compare their efficacy and side-effects. Mean age at tx was 4.2 years for Tac and 5.8 years for Cya. Mean follow-up was 26 months (range: 11-39 months) for Tac and 24 months for Cya (range: 33-13 months). RESULTS: Our data suggest that both regimens are efficacious in the pediatric population. Conversion from Cya to Tac was useful for dealing with persistent rejection, although this sample did not suggest lower incidence of acute cellular rejection in the Tac group. CONCLUSIONS: Further studies are required to establish pharmacokinetic parameters to enhance therapeutic monitoring of these patients to minimize side effects and enhance outcomes.  相似文献   
63.
64.
PROBLEM: To develop a methodology to determine a) the leukocytic contribution to reactive oxygen species generation by human sperm suspensions and b) the therapeutic value of removing these cellular contaminants. METHODS: Leukocytes were removed with paramagnetic beads or colloidal ferrofluids coated with anti-CD45 antibody. The sperm suspensions were monitored for oxidant generation by chemiluminescence, leukocyte contamination by immunocytochemistry, and fertilizing potential using zona-free hamster oocytes. RESULTS: Percoll®-prepared human sperm suspensions exhibited a competence for PMA-induced reactive oxygen species generation which was significantly correlated with leukocyte contamination. However, the purified spermatozoa remaining after paramagnetic bead treatment, also demonstrated an intrinsic capacity for PMA-responsive reactive oxygen species generation and, freed from the oxidative stress created by the leukocytes, exhibited a significantly enhanced capacity for sperm-oocyte fusion. CONCLUSIONS: Although human spermatozoa can generate reactive oxygen species, sperm function is inhibited by the additional oxidative stress created by contaminating leukocytes. Removal of these cells with paramagnetic beads enhances fertilizing potential.  相似文献   
65.
Gastric campylobacter-like organisms (CLO) were isolated from gastric tissues removed at sacrifice from 17 mature ferrets; all animals were colonized, but no macroscopic mucosal lesions or histological features of chronic gastritis were seen. The isolates resembled Campylobacter pylori in many cultural and biochemical characteristics, and produced substantial urease activity, but there were sufficient differences from C. pylori to suggest that ferret gastric CLO represents a separate species. Comparison of human C. pylori and ferret gastric CLO may help to elucidate the pathogenicity of the former in patients with gastritis, and the ferret may serve as a useful animal model for the study of C. pylori infection.  相似文献   
66.
OBJECTIVE: The aim was to establish the potential efficacy, tolerabilityand side-effect profile of electromagnetic therapy as an adjunctto conventional dressings in the treatment of venous leg ulcers. METHOD: A prospective, randomized, double blind controlled clinicaltrial was carried out in a dedicated leg ulcer clinic basedin one urban general practice. Nineteen patients with leg ulcersof confirmed venous aetiology were assessed. The main outcomemeasures were rate and scale of venous leg ulcer healing, changesin patient-reported pain levels, quality of life, degree ofmobility, side effect profile and acceptability to patientsand staff. RESULTS: Sixty-eight per cent of patients attending this dedicated clinicachieved improvements in the size of their ulcer (4, 21%, healedfully) and in reduced pain levels (P < 0.05) during the trial,despite the chronicity of ulcer histories. Patients treatedwith electromagnetic therapy at 800 Hz were found at day 50to have significantly greater healing (P < 0.05) and paincontrol (P < 0.05) than placebo therapy or treatment with600 Hz. All patients reported improved mobility at the end ofthe study. The electromagnetic therapy was well tolerated bypatients, with no differences between groups in reporting adverseevents, and proved acceptable to staff. CONCLUSION: Despite the small numbers in this pilot study, electromagnetictherapy provided significant gains in the healing of venousleg ulcers and reduction in pain. Keywords. Electromagnetic therapy, RCT, leg ulcers, primary care.  相似文献   
67.
Bile duct calculi in patients with primary sclerosing cholangitis   总被引:1,自引:0,他引:1  
  相似文献   
68.
69.
实验性视网膜光化学损伤中的蛋白激酶C   总被引:2,自引:0,他引:2  
目的:研究实验性视网膜光化学损伤中蛋白激酶C(protein kinase C,PKC)活性的改变;探索地塞米松(dexamethasone,DXM)对视网膜中PKC活性的影响。 方法;48只SD大鼠分为对照组和DXM组,后者于光照前3天开始,连续5天腹膜腔注射DXM 1mg/(kg·d)。经(1 900±106.9)Ix的绿色荧光灯(λ=510nm~560nm)连续照射24小时后的6小时和1、3、7、14天,进行视网膜PKC活性检测。 结果:光化学损伤后视网膜中的PKC活性在短暂的上升后即出现持续性的下降;DXM对PKC的活性改变无明显作用。 结论:光化学损伤中的视网膜功能障碍可能与PKC活性的持续降低有关。 (中华眼底病杂志,1997,13:78-80)  相似文献   
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号